Focused insights, better outcomes.
Committed to advance our research by fostering new concepts, refining methodologies, challenging status quo, and expanding our knowledge.
The latest whitepapers.
Our most recent exploratory thought-leadership articles, provided here for comment and feedback.
AI HEOR Dashboards (opens in a new tab)
- Sekhar Kumar Dutta
- Sheetal Sharma
- Subhajit Gupta
- Ray Gani
Effective market access requires rapid, transparent, evidence-driven communications to a diverse set of payers, yet traditional HEOR dashboard development typically takes two teams weeks to deliver…
02WhitepaperApr 2026
AI HTA & Global Value Dossier (opens in a new tab)
- Sheetal Sharma MSc, EVP
- Pixy Banerjee MPharm, AVP, HEVA
- Subhajit Gupta MSc, VP, AI
Global value dossier (GVD) development is critical to market access yet often constrained by fragmented evidence and inconsistent value narratives. AI-powered GVDs represent a step change…
Read more03WhitepaperApr 2026
AI Health Economic Modelling (opens in a new tab)
- Ray Gani PhD, EVP
- Subhajit Gupta MSc, VP
The Claude Microsoft Excel add-in released in January 2026 enables Excel-based health economic models to be quickly generated. But there are substantial limitations which can be overcome…
Read moreOur work.
26 resources across manuscripts, whitepapers, webinars, case studies and conference publications.
Filter by type
From cutting-edge medical innovations to evidence-based practices, delve into a wealth of knowledge that shapes the future of healthcare. Stay informed, stay empowered, with our comprehensive repository of healthcare research manuscripts
01Transition Probability EstimationJan 2025
Economic Evaluation, Transition Probability Estimation (opens in a new tab)
Bollée M, Dutta Majumdar A
Discrete-time Markov cohort-state transition models are now well-established as the preferred choice of analysts across application areas including health technology assessment…
Read more02Acne Vulgaris
Network Meta-Analysis, Acne Vulgaris (opens in a new tab)
Harper CJ, Baldwin H, Paul Choudhury S, Rai D, Ghosh B, Sohail MD, Choudhury AR, Dutta SK
Multiple treatment options exist for the management of moderate-to-severe acne. However, the comparative effectiveness (efficacy/safety) of moderate-to-severe acne treatments remains unclear…
Read more03Macular Edema Associated With Uveitis
RWE Analysis, Macular Edema Associated With Uveitis (opens in a new tab)
Hariprasad SM, Joseph G, Gagnon-Sanschagrin P, Serra E, Bhattacharyya S, Bédard J, Guérin A
Healthcare costs among patients with macular oedema associated with non-infectious uveitis: a US commercial payer's perspective. BMJ Open Ophthalmology. 2021.
Read more04Macular Edema Associated With Uveitis
Cost-Effectiveness Analysis, Macular Edema Associated With Uveitis (opens in a new tab)
Bhattacharyya S, Hariprasad SM, Albini TA, Dutta SK, John D, Padula WV, Harrison D, Joseph G
Suprachoroidal Injection of Triamcinolone Acetonide Injectable Suspension for the Treatment of Macular Edema Associated With Uveitis in the United States: A Cost-Effectiveness Analysis…
Read more05Acne Vulgaris
Quality of Life, Acne Vulgaris (opens in a new tab)
Gold LS, Harding G, Borroto D, Choudhury SP, Dutta SK, Kamleh M, Joseph G, Dashputre AA
Post-Hoc Exploratory Pooled Analysis of the Impact of IDP-126 Gel on QoL in Moderate-to-Severe Acne. Journal of Drugs in Dermatology: JDD. 2023 Oct 1;22(10):1033–9…
Read more
Schedule a meeting.
Stay up to date with the latest news, announcements, and articles
PharmaQuant on LinkedIn (opens in a new tab)